PRECIOUS

€8.3 million EU grant awarded to international ‘PRECIOUS’ consortium to integrate nanomedicines and immunotherapy to attack cancer

€8.3 million EU grant awarded to international ‘PRECIOUS’ consortium to integrate nanomedicines and immunotherapy to attack cancer

An international multi-disciplinary consortium of 11 partners, in which 5 leading academic institutes, 4 cutting-edge biotech companies and 2 excellent service providers will join forces to advance the treatment of cancer using an innovative immunotherapeutic nanomedicin, has received an €8.3 million Horizon 2020 grant (grant agreement No 686089). The PRECIOUS consortium will be coordinated byRead more about €8.3 million EU grant awarded to international ‘PRECIOUS’ consortium to integrate nanomedicines and immunotherapy to attack cancer[…]